Jeryl L Hilleman's Net Worth
$11.4 Million
Who is Jeryl L Hilleman?
Jeryl L Hilleman has an estimated net worth of $11.4 Million. This is based on reported shares across multiple companies, which include AMYRIS, INC., SYMYX TECHNOLOGIES INC, NovoCure Ltd, SI-BONE, Inc., Intersect ENT, Inc., Talis Biomedical Corp, Minerva Neurosciences, Inc., HilleVax, Inc., XENOPORT INC, and Ocera Therapeutics, Inc..
SEC CIK
Jeryl L Hilleman's CIK is 0001216628
Past Insider Trading and Trends
2018 was Jeryl L Hilleman's most active year for acquiring shares with 13 total transactions. Jeryl L Hilleman's most active month to acquire stocks was the month of April. 2005 was Jeryl L Hilleman's most active year for disposing of shares, totalling 104 transactions. Jeryl L Hilleman's most active month to dispose stocks was the month of April. 2019 saw Jeryl L Hilleman paying a total of $769,882.35 for 188,087 shares, this is the most they've acquired in one year. In 2019 Jeryl L Hilleman cashed out on 105,948 shares for a total of $1,742,005.01, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
AMYRIS, INC. (AMRSQ) Snapshot price: $0.001
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -28.78% | -3.60K |
$15.97 | -$86,631.17 | 8.91K |
Scheduled
|
May 20
| ||
Form 4
| -34.55% | -9.40K |
$15.97 | -$227,976.55 | 17.81K |
Scheduled
|
May 18 - May 19
| ||
Form 4
| -63.33% | -16.11K |
$15.11 | -$867,939.15 | 9.33K |
Scheduled
|
Apr 15
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SYMYX TECHNOLOGIES INC No price found
Exec. Vice President and CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -9.06% | -9.65K |
$16.65 | -$160,705.80 | 96.85K |
Mar 1
| |||
Form 4
| +294.44% | 79.5K |
—
|
—
| 106.5K |
Feb 12
| |||
Form 4
|
—
|
0
|
$15.72 | -$270,482.71 | 3.43K |
Scheduled
|
May 1 - May 2
| ||
Form 4
|
∞
| 27K |
—
|
—
| 27K |
Mar 1
| |||
Form 4
|
—
|
0
|
$13.85 | -$257,757.33 | 3.43K |
Scheduled
|
Feb 15 - Feb 16
| ||
Form 4
|
—
|
0
|
$13.71 | -$145,604.27 | 3.43K |
Scheduled
|
Nov 2
| ||
Form 4
|
—
|
0
|
$13.63 | -$108,626.07 | 3.43K |
Scheduled
|
Nov 1
| ||
Form 4
|
—
|
0
|
$14.76 | -$51,992.31 | 3.43K |
Scheduled
|
Aug 11
| ||
Form 4
|
—
|
0
|
$14.93 | -$94,160.04 | 3.43K |
Scheduled
|
Aug 9 - Aug 10
| ||
Form 4
|
—
|
0
|
$14.82 | -$72,279.44 | 3.43K |
Scheduled
|
Aug 3
| ||
Form 4
|
—
|
0
|
$15.38 | -$65,926.08 | 3.43K |
Scheduled
|
Aug 1 - Aug 2
| ||
Form 4
| -46.30% | -2.96K |
$24.82 | -$73,382.15 | 3.43K |
Scheduled
|
May 12 - May 13
| ||
Form 4
| -32.06% | -3.01K |
$26.00 | -$78,371.43 | 6.39K |
Scheduled
|
May 9 - May 10
| ||
Form 4
| -30.00% | -4.03K |
$25.43 | -$102,468.24 | 9.4K |
Scheduled
|
May 4
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
| -42.68% | -10.00K |
$26.73 | -$267,301.82 | 13.43K |
Scheduled
|
Feb 23 - Feb 24
| ||
Form 4
| -29.91% | -10.00K |
$24.94 | -$249,412.60 | 23.43K |
Scheduled
|
Feb 16
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 1
| |||
Form 4
| -13.01% | -5.00K |
$26.46 | -$132,299.53 | 33.43K |
Scheduled
|
Nov 9
| ||
Form 4
| -11.51% | -5.00K |
$25.87 | -$129,328.00 | 38.43K |
Scheduled
|
Nov 2
| ||
Form 4
| -10.32% | -5.00K |
$20.47 | -$102,344.00 | 43.43K |
Scheduled
|
Sep 28
| ||
Form 4
| -9.36% | -5.00K |
$21.74 | -$108,712.00 | 48.43K |
Scheduled
|
Sep 21
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
| -15.77% | -10.00K |
$24.70 | -$247,000.00 | 53.43K |
Scheduled
|
May 13
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
| -13.62% | -10.00K |
$25.39 | -$253,940.00 | 63.43K |
Scheduled
|
Feb 25
| ||
Form 4
| -11.99% | -10.00K |
$20.12 | -$201,200.00 | 73.43K |
Scheduled
|
Nov 4
| ||
Form 4
| -14.73% | -14.41K |
$24.46 | -$352,444.14 | 83.43K |
Scheduled
|
Sep 3
| ||
Form 4
| -5.41% | -5.59K |
$24.60 | -$137,532.90 | 97.84K |
Sep 2
| |||
Form 4
| -0.29% | -300.00 |
—
|
—
| 103.43K |
Jul 30
| |||
Form 4
| -100.00% | -1.20K |
$23.76 | -$28,506.26 |
0
|
Jul 29
| |||
| No matching records found | |||||||||
NovoCure Ltd (NVCR) Snapshot price: $14.89
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
| -13.82% | -407.00 |
$69.61 | -$28,331.27 | 2.54K |
Scheduled
|
Jun 10
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
| -5.99% | -456.00 |
$210.01 | -$266,712.70 | 7.16K |
Scheduled
|
Jun 9
| ||
Form 4
| -42.37% | -2.50K |
$166.40 | -$416,000.00 | 3.4K |
Scheduled
|
Dec 18
| ||
Form 4
| +75.65% | 2.54K |
—
|
—
| 5.9K |
Jun 10
| |||
Form 4
|
∞
| 3.36K |
—
|
—
| 3.36K |
May 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 31
| |||
| No matching records found | |||||||||
SI-BONE, Inc. (SIBN) Snapshot price: $20.59
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -21.33% | -4.16K |
$28.37 | -$118,075.94 | 15.35K |
Jun 15 - Jun 20
| |||
Form 4
| +33.23% | 4.87K |
—
|
—
| 19.51K |
Jun 9
| |||
Form 4
| +131.69% | 8.32K |
—
|
—
| 14.64K |
Jun 16
| |||
Form 4
| -23.34% | -1.92K |
$13.81 | -$26,561.97 | 6.32K |
Scheduled
|
Jun 13
| ||
Form 4
| -34.80% | -4.40K |
$33.71 | -$148,324.00 | 8.24K |
Scheduled
|
Jun 25
| ||
Form 4
| +43.74% | 3.85K |
—
|
—
| 12.64K |
Jun 10
| |||
Form 4
|
∞
| 8.8K |
—
|
—
| 8.8K |
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Intersect ENT, Inc. No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +37.49% | 11.95K |
—
|
—
| 43.84K |
May 7
| |||
Form 4
|
—
|
0
|
$23.56 | -$883,111.17 | 31.88K |
Scheduled
|
Apr 1 - Apr 2
| ||
Form 4
| +60.35% | 12K |
—
|
—
| 31.88K |
Jan 16
| |||
Form 4
| -15.14% | -3.55K |
$26.57 | -$94,261.49 | 19.88K |
Jan 1
| |||
Form 4
|
—
|
0
|
$19.91 | -$207,545.08 | 23.43K |
Scheduled
|
Oct 8
| ||
Form 4
|
—
|
0
|
$20.02 | -$228,458.20 | 23.43K |
Scheduled
|
Sep 14
| ||
Form 4
|
—
|
0
|
$26.41 | -$392,442.12 | 23.43K |
Scheduled
|
Jun 5
| ||
Form 4
|
—
|
0
|
$25.53 | -$369,865.03 | 23.43K |
Scheduled
|
May 3
| ||
Form 4
|
—
|
0
|
$24.39 | -$340,544.19 | 23.43K |
Scheduled
|
Apr 3
| ||
Form 4
|
—
|
0
|
$23.52 | -$318,267.38 | 23.43K |
Scheduled
|
Mar 6
| ||
Form 4
|
—
|
0
|
$23.46 | -$316,691.49 | 12.93K |
Scheduled
|
Feb 6
| ||
Form 4
| +81.19% | 10.5K |
—
|
—
| 23.43K |
Jan 17
| |||
Form 4
|
—
|
0
|
$22.47 | -$291,164.54 | 12.93K |
Scheduled
|
Jan 11
| ||
Form 4
| -13.79% | -2.07K |
$33.93 | -$70,173.03 | 12.93K |
Jan 1
| |||
Form 4
|
—
|
0
|
$20.59 | -$243,109.64 | 15K |
Scheduled
|
Dec 4
| ||
Form 4
|
—
|
0
|
$19.45 | -$213,826.01 | 15K |
Scheduled
|
Nov 6
| ||
Form 4
|
—
|
0
|
$20.54 | -$241,796.82 | 15K |
Scheduled
|
Oct 4
| ||
Form 4
|
—
|
0
|
$21.09 | -$255,759.12 | 15K |
Scheduled
|
Sep 5
| ||
Form 4
|
—
|
0
|
$20.06 | -$229,506.66 | 15K |
Scheduled
|
Aug 4
| ||
Form 4
|
—
|
0
|
$19.15 | -$206,092.88 | 15K |
Scheduled
|
Jul 10
| ||
Form 4
|
∞
| 15K |
—
|
—
| 15K |
Jan 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||